Hi mate,
Appreciate your contributions to this forum and sorry to hear about your disappointment with the CR.
Me trying to put some of the jigsaw puzzle together:$2 million to increase the size of existing shareholding and become a substantial shareholder".
- One point from the CR ANN - "Placement received cornerstone support from strategic US investor, who has agreed to invest
- I'd suggest that the CR (in part and IMO) is a strategic move to help unlock various opportunities and relationships within the US.
- The August Interview with Sven - Bahay made a point of touching on the US Oil & Gas market and how challenging it was becoming for these companies, and that Parkway were working with a number of big players there.
- Also, I don't know if it was a slip during the recent interview when Bahay said that these modular plants were being designed and built "imminently".
Sometimes, I'll revisit old ANN's and past interviews because what I didn't fully comprehend back then makes more sense now.
Also, it's a useful tool to check if the company has strayed from what was mentioned even 2 or 3 years ago.
IMO, nothing that's been said in interviews or ANN's released has been contradictory.
As the recent news flow has been good, I don't see why it wouldn't continue. The excitement and interest in the company is clearly gaining momentum.
They've ticked of some major milestones recently whilst working tirelessly to get their technology into the market.
Now and then I remind myself that Bahay's in the driver's seat so he's always going to be a dozen steps ahead of me, so whatever is not clear now will likely be in the future.
- Forums
- ASX - By Stock
- Ann: Placement Raises $4M to Fund Growth Initiatives
Hi mate,Appreciate your contributions to this forum and sorry to...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PWN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.001(8.33%) |
Mkt cap ! $35.97M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $8.251K | 659.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 2942133 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 2308892 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 2942133 | 0.012 |
13 | 9406290 | 0.011 |
7 | 1774220 | 0.010 |
8 | 1892009 | 0.009 |
7 | 1838945 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 2308892 | 5 |
0.014 | 6556222 | 6 |
0.015 | 1709817 | 6 |
0.016 | 2101066 | 4 |
0.017 | 2412860 | 2 |
Last trade - 15.08pm 12/11/2024 (20 minute delay) ? |
Featured News
PWN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online